KindlyMD Secures $710M to Revolutionize Pain Management and Confront the Opioid Crisis

KindlyMD, Inc. is proud to announce the successful raising of $710,000,000 in our latest funding round, a transformative milestone in our journey to reshape medication management and patient care. With refreshing and advanced methodologies, KindlyMD™️ offers a thoughtful, compassionate, and evidence-based approach to medication management, focusing on uniquely patient-centered care programs. Our work is particularly vital for patients grappling with pain, PTSD, depression, anxiety, chronic pain, addiction, and many other challenging conditions. In an era where the opioid epidemic has left countless lives disrupted, our innovative model—grounded in integrated behavioral health care, alternative medication therapies, and compassionate oversight—ensures that patients no longer have to suffer from a system that overlooks their individuality. This substantial funding will not only accelerate the expansion of our services as the largest alternative medicine group in Utah but also empower our dedicated teams to further refine data-driven strategies and collaborative treatment plans. By investing in cutting-edge technology and best practices from a wide array of disciplines, we are better positioned to tackle the stigmas associated with chronic pain management and provide effective, safe solutions. Our commitment to treating the whole person, rather than relying solely on rigid medication titration, demonstrates our unwavering determination to stem the tide of an epidemic that has affected so many lives. As we embark on the next phase of growth, this funding propels us closer to our vision of a healthcare landscape where every patient receives not only the medical attention they need, but also the empathy and support that inspires hope for a better quality of life.